To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Autologous Bone Marrow-Derived Chondrocytes for Patients with Knee Osteoarthritis

Download
Share
Reprints
Cite This
About
+ Favorites
Download
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
January 2022

Autologous Bone Marrow-Derived Chondrocytes for Patients with Knee Osteoarthritis

Vol: 166| Issue: 1| Number:1| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Autologous Bone Marrow-Derived Chondrocytes for Patients with Knee Osteoarthritis: A Randomized Controlled Trial.

Adv Orthop. 2021 Nov 20;2021: 2146722.

Contributing Authors:
M Sadat-Ali AS AlOmran SA AlMousa HN AlSayed KW AlTabash MQ Azam TM Hegazi S Acharya

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

Sixty patients aged 45-70 years old with knee osteoarthritis were randomized to receive a single intra-articular injection of autologous bone marrow-derived chondrocytes (n=30) or physical therapy and nonsteroidal anti-inflammatory drugs (NSAIDs). Outcomes of interest included pain on a Visual Analog Scale (VAS) with and without movement, the Modified Knee Society Score-Short Form (KSSSF), Activit...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue